No trials specifically enrolled elderly individuals, those with significant cardiovascular disease, individuals with active cancer, or pregnant/breastfeeding women
Another study of 125,474 people with obesity or who are overweight found that almost 47% of those with Type 2 diabetes and nearly 65% of those without diabetes stopped taking GLP-1s within a year a high rate, said Ezekiel Emanuel, a health services researcher at the University of Pennsylvania and senior author of the study
Peptide decision path Move from research interest to supervised review Direct answer Best Time to Use GHK-Cu: What Human Evidence Actually Supports should be evaluated through research status, legal access, source quality, safety context, and clinician oversight rather than a shortcut purchase decision
This is not a medical prediction or guarantee of outcomes
A person with 100 pounds to lose may lose more total pounds than someone with 30 pounds to lose, even if their percentage loss is similar